E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/30/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Advanced Healthcare raises A$10 million from convertibles

By Sheri Kasprzak

New York, March 30 - Advanced Healthcare Group Ltd. settled a A$10 million private placement of convertible notes with Hawkbridge Private Equities.

The company will receive an initial funding of A$7.5 million from the facility, which bears interest at 10% annually and matures in four years.

The notes are convertible into common shares at the lesser of A$0.02 or 90% of the average share price over 30 trading days.

Proceeds will be used for working capital.

Located in Balcatta, Western Australia, Advanced Healthcare Group distributes pharmaceutical and other products in Indonesia and Australia and also conducts research and development on novel human and animal pharmaceutical and vaccine products.

Issuer:Advanced Healthcare Group Ltd.
Issue:Convertible notes
Amount:A$10 million
Maturity:Four years
Coupon:10%
Price:Par
Yield:10%
Conversion price:A$0.02
Warrants:No
Investor:Hawkbridge Private Equities
Settlement date:March 30
Stock symbol:Australia: AHG
Stock price:A$0.035 at close March 30

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.